New Trial Finds VEGF-Inhibitor May Safely Boost Mesothelioma...

Researchers say cediranib has “tolerable toxicity” and “promising efficacy” in the treatment of malignant mesothelioma.(PRWeb June 18, 2017)Read the full story at http://www.prweb.com/releases/2017/06/prweb14436904.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news